Short Descr | Castleman disease |
CMS-HCC v22 | 48 - Coagulation Defects and Other Specified Hematological Disorders |
CMS-HCC v24 | 48 - Coagulation Defects and Other Specified Hematological Disorders |
CMS-HCC v28 | 21 - Lymphoma and Other Cancers |
ESRD-HCC v21 | 48 - Coagulation Defects and Other Specified Hematological Disorders |
ESRD-HCC v24 | 48 - Coagulation Defects and Other Specified Hematological Disorders |
HHS-HCC v07 | 75 - Coagulation Defects and Other Specified Hematological Disorders |
Rx-HCC v08 | 21 - Lymphomas and Other Hematologic Cancers |
Home Health Clinical Group | MMTA_INFECT |
Date
|
Action
|
Notes
|
---|---|---|
2021-10-01 | Changed | Grammar change |
2020-10-01 | Changed | Changed code. Revised code in Excludes2 |
2016-10-01 | Added | Code Added. |
Code
|
Description
|
---|---|
A4641 | Radiopharmaceutical, diagnostic, not otherwise classified |
A9513 | Lutetium lu 177, dotatate, therapeutic, 1 millicurie |
A9515 | Choline c-11, diagnostic, per study dose up to 20 millicuries |
A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
A9580 | Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries |
A9587 | Gallium ga-68, dotatate, diagnostic, 0.1 millicurie |
A9588 | Fluciclovine f-18, diagnostic, 1 millicurie |
A9593 | Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie |
A9594 | Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie |
A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie |
A9607 | Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie |
A9800 | Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie |
C9067 | Gallium ga-68, dotatoc, diagnostic, 0.01 mci |
G0235 | Pet imaging, any site, not otherwise specified |
G0429 | Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy) |
G9147 | Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration |
J1815 | Injection, insulin, per 5 units |
J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units |
J9070 | Cyclophosphamide, 100 mg [deleted] |
J9151 | Injection, daunorubicin citrate, liposomal formulation, 10 mg |
J9165 | Injection, diethylstilbestrol diphosphate, 250 mg |
J9190 | Injection, fluorouracil, 500 mg |
J9215 | Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu |
J9270 | Injection, plicamycin, 2.5 mg |
L8000 | Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type |
L8001 | Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, unilateral, any size, any type |
L8002 | Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, bilateral, any size, any type |
L8010 | Breast prosthesis, mastectomy sleeve |
L8015 | External breast prosthesis garment, with mastectomy form, post mastectomy |
L8020 | Breast prosthesis, mastectomy form |
L8030 | Breast prosthesis, silicone or equal, without integral adhesive |
L8031 | Breast prosthesis, silicone or equal, with integral adhesive |
L8032 | Nipple prosthesis, prefabricated, reusable, any type, each |
L8033 | Nipple prosthesis, custom fabricated, reusable, any material, any type, each |
L8035 | Custom breast prosthesis, post mastectomy, molded to patient model |
L8039 | Breast prosthesis, not otherwise specified |
L8040 | Nasal prosthesis, provided by a non-physician |
L8041 | Midfacial prosthesis, provided by a non-physician |
L8042 | Orbital prosthesis, provided by a non-physician |
L8043 | Upper facial prosthesis, provided by a non-physician |
L8044 | Hemi-facial prosthesis, provided by a non-physician |
L8045 | Auricular prosthesis, provided by a non-physician |
L8046 | Partial facial prosthesis, provided by a non-physician |
L8047 | Nasal septal prosthesis, provided by a non-physician |
L8048 | Unspecified maxillofacial prosthesis, by report, provided by a non-physician |
L8049 | Repair or modification of maxillofacial prosthesis, labor component, 15 minute increments, provided by a non-physician |
L8600 | Implantable breast prosthesis, silicone or equal |
L8603 | Injectable bulking agent, collagen implant, urinary tract, 2.5 ml syringe, includes shipping and necessary supplies |
L8610 | Ocular implant |
Q2017 | Injection, teniposide, 50 mg |
Q2026 | Injection, radiesse, 0.1 ml |
Q2028 | Injection, sculptra, 0.5 mg |
Q3031 | Collagen skin test |
Q9951 | Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml |
Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
Q9959 | High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml |
Q9960 | High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml |
Q9961 | High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml |
Q9962 | High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml |
Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
Q9964 | High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml |
Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
S5550 | Insulin, rapid onset, 5 units |
S5551 | Insulin, most rapid onset (lispro or aspart); 5 units |
S5552 | Insulin, intermediate acting (nph or lente); 5 units |
S5553 | Insulin, long acting; 5 units |
S5560 | Insulin delivery device, reusable pen; 1.5 ml size |
S5561 | Insulin delivery device, reusable pen; 3 ml size |
S5565 | Insulin cartridge for use in insulin delivery device other than pump; 150 units |
S5566 | Insulin cartridge for use in insulin delivery device other than pump; 300 units |
S5570 | Insulin delivery device, disposable pen (including insulin); 1.5 ml size |
S5571 | Insulin delivery device, disposable pen (including insulin); 3 ml size |
V2623 | Prosthetic eye, plastic, custom |
V2624 | Polishing/resurfacing of ocular prosthesis |
V2625 | Enlargement of ocular prosthesis |
V2626 | Reduction of ocular prosthesis |
V2627 | Scleral cover shell |
V2628 | Fabrication and fitting of ocular conformer |
V2629 | Prosthetic eye, other type |
No matching codes found |
Code
|
Description
|
---|---|
238.79 | Other lymphatic and hematopoietic tissues |
No matching codes found |